Study of electroconvulsive therapy (ECT) patients in France
Part of Mental health clinical trials.
This trial follows people who have been referred for electroconvulsive therapy (ECT), a treatment used for certain severe mental health conditions. The study aims to learn about how ECT is used in real-world care and what outcomes may look like for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being referred for electroconvulsive therapy (ECT).
- You are being included as part of a continuous/ongoing patient group referred for ECT.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for ways to predict how well electroconvulsive therapy (ECT) will work for severe depression. It may help doctors choose the best treatment approach and timing for future patients.
This study looks at how ECT affects brain activity and inflammation in older adults with depression. It may help researchers understand why ECT works and improve treatment.
This study looks at “neural biomarkers,” or brain-measurement signals, to see who is most likely to benefit from electroconvulsive therapy (ECT). It focuses on people with certain active psychosis symptoms and specific mental health diagnoses who have tried antipsychotic medication without enough improvement.
This trial studies better ways to deliver ECT (electroconvulsive therapy) for people with difficult-to-treat depression, including some people with bipolar depression. You may be offered an ECT strategy that’s tailored to your situation, with the goal of improving outcomes and reducing problems.
This study helps doctors find the best settings for electroconvulsive therapy (ECT), a treatment for severe depression and other mental health conditions. Researchers will use special monitoring equipment to measure brain activity during your ECT sessions to improve how the treatment works.
This study measures changes in your blood and/or body chemistry while you receive electroconvulsive therapy (ECT) for a severe mood episode. The goal is to understand biological signals related to ECT and treatment-resistant depression, which may help improve future care.
Hear when a new Mental Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.